Cochrane · systematic review · CD012643

Interim PET‐results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta‐analysis of prognostic factor studies

Aldin, A, Umlauff, L, Estcourt, LJ, et al. · Cochrane Database of Systematic Reviews · 2020 · Cochrane Library

Haematology2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
4
No studies
1
Included studies
NR
No studies 1 · 20%Ungraded 0 · 0%Very low 1 · 20%Low 1 · 20%Moderate 2 · 40%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Show all 2 versions

Comparison of interim PET‐negative and interim PET‐positive individuals with Hodgkin Lymphoma

Population: Individuals with Hodgkin lymphoma
5 questions
OutcomeEffectEvidenceStatus / GRADE
Overall survival
HR 5.09 [2.64, 9.81]9 studies · 1802 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency
Progression‐free survival
HR 4.9 [3.47, 6.9]14 studies · 2079 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Adverse events associated with PET ‐ not reported
no estimate extractedNRNo studies
Overall survival (adjusted effect estimate)
no estimate extracted2 studies · 843 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency
Progression‐free survival (adjusted effect estimate)
no estimate extracted4 studies · 996 participantsLow
Downgraded: risk of bias, imprecision, inconsistency